anti-tau IgG4P mAb (UCB)

N/A

Report date: 2025/03/14 16:39:07

Base Information

Drug Nameanti-tau IgG4P mAb (UCB)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionMicrotubule-associated protein tau inhibitors

TargetsMicrotubule-associated protein tau

Therapy Area/IndicationsSupranuclear Palsy, Progressive

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUcb Sa

China Registration ClassN/A

Develop Information

Active CompaniesUcb Sa

Inactive CompaniesN/A

Active IndicationsSupranuclear Palsy, Progressive

Inactive IndicationsN/A

Other Information

ATC CodeN/A